SCHEMBL5633189

SCHEMBL5633189

CC(CC1OC(SCC(F)(F)F)C(O)C(O)C1O)C(N)=O

nearest known ligand 0.36

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
LGALS3 P17931 4/20 0.34
FUCA1 P04066 2/20 0.32
LGALS1 P09382 2/20 0.31
LGALS9 O00182 1/20 0.31
LGALS8 O00214 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5199046 0.80 LGALS3 (0.38) LGALS3LGALS1LGALS9LGALS8
SCHEMBL5199523 0.80 LGALS3 (0.36) LGALS3LGALS1LGALS9LGALS8
SCHEMBL5198276 0.79 LGALS3 (0.38) LGALS3LGALS1LGALS9LGALS8
SCHEMBL4861026 0.75 FUCA1 (0.31) FUCA1
SCHEMBL5197120 0.73 IDUA (0.36)
SCHEMBL5198747 0.73 IDUA (0.36) LGALS3
SCHEMBL5197875 0.72 IDUA (0.33)
SCHEMBL5197001 0.72 PYGB (0.41) LGALS3LGALS1LGALS9LGALS8
SCHEMBL5199500 0.71 IDUA (0.34)
SCHEMBL4861032 0.70 FUCA1 (0.35) FUCA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-2007516172-A 2007-06-21 JP claimed
EP-1644393-A2 NOVEL LINCOMYCIN DERIVATIVES POSSESSING ANTIMICROBIAL ACTIVITY Vicuron Pharmaceuticals, Inc. (US) 2006-04-12 EP claimed
WO-2005012320-A2 NOVEL LINCOMYCIN DERIVATIVES POSSESSING ANTIMICROBIAL ACTIVITY VICURON PHARMACEUTICALS, INC. (US) 2005-02-10 WO claimed
EP-1644393-A2 NOVEL LINCOMYCIN DERIVATIVES POSSESSING ANTIMICROBIAL ACTIVITY Vicuron Pharmaceuticals, Inc. (US) 2006-04-12 EP disclosed
WO-2005012320-A2 NOVEL LINCOMYCIN DERIVATIVES POSSESSING ANTIMICROBIAL ACTIVITY VICURON PHARMACEUTICALS, INC. (US) 2005-02-10 WO disclosed